C. Lawrence

416 total citations
18 papers, 311 citations indexed

About

C. Lawrence is a scholar working on Hematology, Physiology and Genetics. According to data from OpenAlex, C. Lawrence has authored 18 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Physiology and 6 papers in Genetics. Recurrent topics in C. Lawrence's work include Erythrocyte Function and Pathophysiology (7 papers), Hemoglobinopathies and Related Disorders (5 papers) and Blood groups and transfusion (4 papers). C. Lawrence is often cited by papers focused on Erythrocyte Function and Pathophysiology (7 papers), Hemoglobinopathies and Related Disorders (5 papers) and Blood groups and transfusion (4 papers). C. Lawrence collaborates with scholars based in United States, France and United Kingdom. C. Lawrence's co-authors include Marguerite M.B. Kay, RL Nagel, ME Fabry, Lesley J. Bruce, M J A Tanner, José R. Romero, M E Fabry, Peter C. Enzinger, R L Nagel and Mitzy Canessa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

C. Lawrence

18 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Lawrence United States 10 127 88 87 85 82 18 311
ST Sawyer United States 7 177 1.4× 33 0.4× 92 1.1× 241 2.8× 107 1.3× 11 397
R Kastally France 12 234 1.8× 166 1.9× 16 0.2× 85 1.0× 126 1.5× 29 513
Masae Matsumoto Japan 9 56 0.4× 77 0.9× 84 1.0× 122 1.4× 71 0.9× 16 308
Alexis Caulier France 9 130 1.0× 74 0.8× 21 0.2× 87 1.0× 164 2.0× 24 311
Guy H. Grayson United States 5 193 1.5× 19 0.2× 30 0.3× 115 1.4× 89 1.1× 7 393
Albert I. Pick Israel 11 50 0.4× 38 0.4× 22 0.3× 56 0.7× 137 1.7× 23 406
Theodoros Marinakis Greece 9 36 0.3× 48 0.5× 111 1.3× 92 1.1× 68 0.8× 17 326
J. D. Hoyer United States 12 133 1.0× 77 0.9× 37 0.4× 209 2.5× 88 1.1× 20 521
PD Emanuel United States 5 45 0.4× 32 0.4× 44 0.5× 221 2.6× 68 0.8× 9 331
L Bonazzi Italy 9 36 0.3× 40 0.5× 30 0.3× 45 0.5× 88 1.1× 14 321

Countries citing papers authored by C. Lawrence

Since Specialization
Citations

This map shows the geographic impact of C. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lawrence more than expected).

Fields of papers citing papers by C. Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lawrence. The network helps show where C. Lawrence may publish in the future.

Co-authorship network of co-authors of C. Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lawrence. A scholar is included among the top collaborators of C. Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lawrence. C. Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Leruste, Amaury, Jérôme Rambaud, Capucine Pïcard, et al.. (2016). Successful pediatric ECMO in a rare case of septic shock due to a community-acquired Legionella infection. Médecine et Maladies Infectieuses. 47(1). 68–70. 5 indexed citations
2.
Hamilton, Betty K., Arjun Law, Lisa Rybicki, et al.. (2015). Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplantation. 50(9). 1235–1240. 25 indexed citations
3.
Meyerhardt, J. A., Keith Stuart, Christiane Fuchs, et al.. (2007). Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer. Annals of Oncology. 18(7). 1185–1189. 63 indexed citations
4.
Bhargava, Pankaj, Andrew X. Zhu, Jeffrey W. Clark, et al.. (2007). A phase II study of pemetrexed in patients (pts) with advanced neuroendocrine tumors (NETs). Journal of Clinical Oncology. 25(18_suppl). 15149–15149. 2 indexed citations
5.
Enzinger, Peter C., Torunn I. Yock, W. Warren Suh, et al.. (2006). Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer. Journal of Clinical Oncology. 24(18_suppl). 4064–4064. 22 indexed citations
6.
Fabry, M E, José R. Romero, Sandra M. Suzuka, et al.. (2000). Hemoglobin C in Transgenic Mice: Effect of HbC Expression from Founders to Full Mouse Globin Knockouts. Blood Cells Molecules and Diseases. 26(4). 331–347. 10 indexed citations
7.
Salhany, James M., et al.. (1995). Differential sensitivity of stilbenedisulfonates in their reaction with band 3 HT (Pro-868-->Leu).. Proceedings of the National Academy of Sciences. 92(25). 11844–11848. 17 indexed citations
8.
Canessa, Mitzy, José R. Romero, C. Lawrence, R L Nagel, & M E Fabry. (1994). Rate of activation and deactivation of K?Cl cotransport by changes in cell volume in hemoglobin SS, CC and AA red cells. The Journal of Membrane Biology. 142(3). 349–62. 28 indexed citations
9.
Bruce, Lesley J., Marguerite M.B. Kay, C. Lawrence, & M J A Tanner. (1993). Band 3 HT, a human red-cell variant associated with acanthocytosis and increased anion transport, carries the mutation Pro-868→Leu in the membrane domain of band 3. Biochemical Journal. 293(2). 317–320. 50 indexed citations
10.
Lü, YiQing, CH Huang, Olga O. Blumenfeld, et al.. (1992). Elliptocytosis associated with an abnormal α glycophorin. Annals of Hematology. 65(2). 106–109. 4 indexed citations
11.
Solomon, Seymour, Bella Richard, & C. Lawrence. (1991). Evaluation of the Criteria for Diagnosis of Chronic Tension-Type Headache. Cephalalgia. 11(11_suppl). 323–324. 1 indexed citations
12.
Lawrence, C., et al.. (1991). Etude de la couverture vaccinale antitétanique des blessés: Intérêt du Vacci-test®. Médecine et Maladies Infectieuses. 21(1). 27–31. 5 indexed citations
13.
Lawrence, C., ME Fabry, & RL Nagel. (1991). The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology. Blood. 78(8). 2104–2112. 46 indexed citations
14.
Lawrence, C., ME Fabry, & RL Nagel. (1991). The unique red cell heterogeneity of SC disease: crystal formation, dense reticulocytes, and unusual morphology. Blood. 78(8). 2104–2112. 1 indexed citations
15.
Kay, Marguerite M.B., Joshua Goodman, Steven R. Goodman, & C. Lawrence. (1990). Membrane protein band 3 alteration associated with neurologic disease and tissue-reactive antibodies.. PubMed. 7(3). 181–99. 16 indexed citations
16.
Lawrence, C., et al.. (1987). Radiographic abnormalities in coagulation factor VII deficiency.. PubMed. 38(1). 64–6. 2 indexed citations
17.
Lawrence, C., et al.. (1983). Spurious red-cell values with the Coulter Counter.. PubMed. 309(15). 925–6. 2 indexed citations
18.
Willens, Howard J., C. Lawrence, William H. Frishman, & Joel A. Strom. (1983). A noninvasive comparison of left ventricular performance in sickle cell anemia and chronic aortic regurgitation. Clinical Cardiology. 6(11). 542–548. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026